Your session is about to expire
← Back to Search
ClearEdge Device for Breast Cancer Surgery
Study Summary
This trial will assess if a new imaging device can improve accuracy of cancer removal in breast conserving surgeries and reduce the need for repeat surgeries.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I've had radiation therapy for cancer in the same breast or for another cancer that included breast tissue.I have not been in any breast cancer studies involving surgery in the last 6 months.I have been diagnosed with breast cancer and recommended for a lumpectomy.I am 18 years old or older.I have received hormone therapy before surgery for my cancer.I have had surgery on the same side breast cancer before.I am genetically female.I am currently undergoing chemotherapy.You have breast implants.
- Group 1: SoC - Standard of Care
- Group 2: SoC+ClearEdge device - Standard of Care + study device
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are currently involved in this research protocol?
"Affirmative. According to the information listed on clinicaltrials.gov, this particular experiment is in need of participants; having been first posted November 18th 2022 and last amended March 14th 2023. It seeks 288 individuals from a single site."
Are there still opportunities for volunteers to join this experiment?
"Agreed. According to clinicaltrials.gov, this research program is actively searching for participants and was originally posted on November 18th 2022 with the date of most recent update being March 14th 2023. The trial requires 288 patients from a single site to reach its enrollment goal."
Share this study with friends
Copy Link
Messenger